Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...

A major mouse study found that some inherited traits are passed down through epigenetic changes that break the classic rules ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...

Key Points Interested in Opus Genetics, Inc.? Here are five stocks we like better. Opus Genetics highlighted a broad ...

Fulgent Genetics enters this update cycle with no changes to its price targets, leaving the existing analyst expectations ...

An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help ...

Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...

As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job.

The rapid advancement of high-throughput sequencing and multi-omics technologies has transformed genetics into an inherently data-intensive discipline. In ...

For more than a century, heredity has been framed through the tidy logic of Mendel’s pea plants: traits pass from parent to ...